4
Changes in Ownership
HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-21-003788
EVP, Drug Development gave up 433 shares (to pay taxes)
- EVP, Drug Development acquired 1,250 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| MANHARD KIMBERLY EVP, Drug Development | 2021-01-13 | Option exercise | +1,250 | 1,250 | D: show line 1 in the form | ||
| MANHARD KIMBERLY EVP, Drug Development | 2021-01-13 | Shares withheld for taxes | −433 | $18.16 | $7,863 | 817 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| MANHARD KIMBERLY EVP, Drug Development | 2021-01-13 | Option exercise · Restricted Stock Units | −1,250 | 18,750 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…